S&P 500   4,263.73 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   360.19 (+1.48%)
AAPL   173.94 (+0.89%)
MSFT   319.75 (+2.03%)
META   306.38 (+1.81%)
GOOGL   135.41 (+2.25%)
AMZN   127.17 (+1.96%)
TSLA   261.34 (+6.01%)
NVDA   439.61 (+1.02%)
NIO   8.81 (+2.32%)
BABA   84.03 (-0.60%)
AMD   104.12 (+4.04%)
T   14.63 (-1.01%)
F   11.98 (-0.75%)
MU   68.16 (+0.49%)
CGC   0.76 (+11.68%)
GE   108.87 (+1.03%)
DIS   79.33 (-0.26%)
AMC   8.38 (+6.75%)
PFE   33.26 (-1.89%)
PYPL   58.56 (+2.20%)
NFLX   375.75 (-0.27%)
S&P 500   4,263.73 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   360.19 (+1.48%)
AAPL   173.94 (+0.89%)
MSFT   319.75 (+2.03%)
META   306.38 (+1.81%)
GOOGL   135.41 (+2.25%)
AMZN   127.17 (+1.96%)
TSLA   261.34 (+6.01%)
NVDA   439.61 (+1.02%)
NIO   8.81 (+2.32%)
BABA   84.03 (-0.60%)
AMD   104.12 (+4.04%)
T   14.63 (-1.01%)
F   11.98 (-0.75%)
MU   68.16 (+0.49%)
CGC   0.76 (+11.68%)
GE   108.87 (+1.03%)
DIS   79.33 (-0.26%)
AMC   8.38 (+6.75%)
PFE   33.26 (-1.89%)
PYPL   58.56 (+2.20%)
NFLX   375.75 (-0.27%)
S&P 500   4,263.73 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   360.19 (+1.48%)
AAPL   173.94 (+0.89%)
MSFT   319.75 (+2.03%)
META   306.38 (+1.81%)
GOOGL   135.41 (+2.25%)
AMZN   127.17 (+1.96%)
TSLA   261.34 (+6.01%)
NVDA   439.61 (+1.02%)
NIO   8.81 (+2.32%)
BABA   84.03 (-0.60%)
AMD   104.12 (+4.04%)
T   14.63 (-1.01%)
F   11.98 (-0.75%)
MU   68.16 (+0.49%)
CGC   0.76 (+11.68%)
GE   108.87 (+1.03%)
DIS   79.33 (-0.26%)
AMC   8.38 (+6.75%)
PFE   33.26 (-1.89%)
PYPL   58.56 (+2.20%)
NFLX   375.75 (-0.27%)
S&P 500   4,263.73 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   360.19 (+1.48%)
AAPL   173.94 (+0.89%)
MSFT   319.75 (+2.03%)
META   306.38 (+1.81%)
GOOGL   135.41 (+2.25%)
AMZN   127.17 (+1.96%)
TSLA   261.34 (+6.01%)
NVDA   439.61 (+1.02%)
NIO   8.81 (+2.32%)
BABA   84.03 (-0.60%)
AMD   104.12 (+4.04%)
T   14.63 (-1.01%)
F   11.98 (-0.75%)
MU   68.16 (+0.49%)
CGC   0.76 (+11.68%)
GE   108.87 (+1.03%)
DIS   79.33 (-0.26%)
AMC   8.38 (+6.75%)
PFE   33.26 (-1.89%)
PYPL   58.56 (+2.20%)
NFLX   375.75 (-0.27%)
OTCMKTS:CHEOF

Cochlear (CHEOF) Stock Forecast, Price & News

$159.80
-3.46 (-2.12%)
(As of 10/3/2023 ET)
Compare
Today's Range
$159.80
▼
$159.80
50-Day Range
$150.29
▼
$176.30
52-Week Range
$118.43
▼
$176.30
Volume
2 shs
Average Volume
257 shs
Market Capitalization
N/A
P/E Ratio
97.32
Dividend Yield
0.79%
Price Target
N/A
ProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest

Cochlear MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.33mentions of Cochlear in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.20 out of 5 stars

See Top Rated MarketRank™ Stocks Here

CHEOF stock logo

About Cochlear (OTCMKTS:CHEOF) Stock

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

CHEOF Price History

CHEOF Stock News Headlines

October 4, 2023 | americanbankingnews.com
Head-To-Head Analysis: Cochlear (OTCMKTS:CHEOF) and Conformis (NASDAQ:CFMS)
October 3, 2023 | americanbankingnews.com
Analyzing Tenon Medical (NASDAQ:TNON) & Cochlear (OTCMKTS:CHEOF)
October 4, 2023 | Behind the Markets (Ad)
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
July 26, 2023 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and Cochlear Limited (OtherCHEOF)
July 20, 2023 | msn.com
Chandy’s Cochlear Implant Scheme hits hurdles, parents seek government help
July 19, 2023 | benzinga.com
Sensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in Europe
July 18, 2023 | msn.com
7-year-old girl hears for first time after Chhattisgarh govt sponsors operation, father wants her to become doctor
July 18, 2023 | msn.com
Oommen Chandy: Humane leader who put patients first, say health experts
October 4, 2023 | Oxford Club (Ad)
AI Stock Caught Trading Under Secret Name
We have uncovered perhaps the most unusual AI stock we've ever seen.It's expected to see massive revenue this year - $215 billion.  The company holds over 29,000 patents in the U.S. It pays an enormous dividend.
July 10, 2023 | markets.businessinsider.com
Morgan Stanley Keeps Their Hold Rating on Cochlear Limited (CHEOF)
July 10, 2023 | benzinga.com
Sensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UK
July 5, 2023 | benzinga.com
Sensorion Reports Positive Efficacy Data from SENS-401 Phase 2a Clinical Study
June 25, 2023 | msn.com
Rajasthan: Govt announces ₹1 lakh airfare for travel for organ transplant
June 25, 2023 | thetimes.co.uk
NHS may have missed thousands of deaf children in ‘huge national failure’
June 22, 2023 | morningstar.com
FTSE 100 Closes Down 0.75% After Rate Hike; Ocado Surges on Bid Speculation
June 22, 2023 | afr.com
Labor bows to pressure on multinational tax disclosure
June 19, 2023 | finance.yahoo.com
Sensorion Reports Promising Preliminary Data from SENS-401 Phase 2a Clinical Study
May 22, 2023 | afr.com
‘Next Cochlear’ stock surges after heart device breakthrough
May 4, 2023 | marketwatch.com
Cochlear Implants Market Share | Business till 2030
May 3, 2023 | msn.com
Parents to inform SA cochlear implant review
April 20, 2023 | msn.com
Townsville University Hospital staff stood down amid review of paediatric audiology unit outcomes
April 16, 2023 | afr.com
Australian business delegation heads to China
April 11, 2023 | msn.com
Surgeries of chronically ill children in Pune pending under RBSK
April 6, 2023 | marketwatch.com
Cochlear Implant (CI) Systems Market 2023-2030| Expert Analysis of Current Trend and Scope to Drive the Market
April 6, 2023 | marketwatch.com
Sensorion Announces Candidate Selection for GJB2 Gene Therapy Program
March 22, 2023 | uk.news.yahoo.com
Dad runs half marathon to help deaf babies like his son
March 22, 2023 | nasdaq.com
Cochlear, Demant contest UK regulator's Oticon deal concerns
See More Headlines
Receive CHEOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CHEOF
CUSIP
N/A
CIK
1453930
Web
www.cochlear.com
Phone
(129) 428-6555
Fax
N/A
Employees
4,800
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
97.32
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover
10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Diggory William Howitt BE (Hons) (Age 56)
    MBA, CEO, MD, Pres & Exec. Director
    Comp: $3.07M
  • Mr. Stuart Sayers
    Chief Financial Officer
  • Mr. Jan Janssen MSc Elec Eng (Age 58)
    Chief Technology Officer
    Comp: $1.31M
  • Ms. Karen O'Driscoll
    Chief Information Officer
  • Ms. Kristina Devon
    VP of Investor Relations
  • Ms. Jennifer Stevenson
    VP of Corp. Communications & Brand
  • Mr. Dean Phizacklea
    Sr. VP of Global Strategic Marketing
  • Ms. Jennifer Hornery
    Sr. VP of Global People & Culture
  • Mr. Greg Bodkin BE (Hons)
    MComm (UNSW), Sr. VP of Global Supply Chain
  • Mr. Anthony Bishop
    Pres of Asia Pacific & Latin America

Key Competitors

View All Competitors













CHEOF Stock - Frequently Asked Questions

How have CHEOF shares performed in 2023?

Cochlear's stock was trading at $135.00 at the beginning of 2023. Since then, CHEOF shares have increased by 18.4% and is now trading at $159.7950.
View the best growth stocks for 2023 here.

Are investors shorting Cochlear?

Cochlear saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 85,300 shares, a decline of 13.6% from the August 31st total of 98,700 shares. Based on an average daily trading volume, of 1,100 shares, the short-interest ratio is currently 77.5 days.
View Cochlear's Short Interest.

Is Cochlear a good dividend stock?

Cochlear (OTCMKTS:CHEOF) pays an annual dividend of $1.27 per share and currently has a dividend yield of 2.07%. The dividend payout ratio is 77.34%. Payout ratios above 75% are not desirable because they may not be sustainable.

What is Cochlear's stock symbol?

Cochlear trades on the OTCMKTS under the ticker symbol "CHEOF."

How do I buy shares of Cochlear?

Shares of CHEOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cochlear's stock price today?

One share of CHEOF stock can currently be purchased for approximately $159.80.

How many employees does Cochlear have?

The company employs 4,800 workers across the globe.

How can I contact Cochlear?

Cochlear's mailing address is 1 University Avenue, Sydney, New South. The official website for the company is www.cochlear.com. The company can be reached via phone at (129) 428-6555.

This page (OTCMKTS:CHEOF) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -